Patent · US Active

Haptens of aripiprazole

US10166296B2 · kind B2 · utility

0Cited by

17References

9Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Ronghui Lin · Ambler, US
Rhys Salter · Doylestown, US
Thomas R. DeCory · Pittsford, US
Eric Hryhorenko · Hilton, US
Bart M. Remmerie · Evergem, BE
Banumathi Sankaran · Lexington, US

Key dates

Filing date	Oct 20, 2017
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Oct 20, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.